BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1047 related articles for article (PubMed ID: 1666447)

  • 21. Varicella-zoster virus-specific cellular immunity in subjects given acyclovir after household chickenpox exposure.
    Kumagai T; Kamada M; Igarashi C; Yuri K; Furukawa H; Chiba S; Kojima H; Saito A; Okui T; Yano S
    J Infect Dis; 1999 Sep; 180(3):834-7. PubMed ID: 10438374
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current management of varicella zoster virus infections.
    Balfour HH
    J Med Virol; 1993; Suppl 1():74-81. PubMed ID: 8245897
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidence, risk factors and outcome of varicella-zoster virus infection in children after haematopoietic stem cell transplantation.
    Leung TF; Chik KW; Li CK; Lai H; Shing MM; Chan PK; Lee V; Yuen PM
    Bone Marrow Transplant; 2000 Jan; 25(2):167-72. PubMed ID: 10673675
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of varicella-zoster virus infections in children.
    Arvin AM
    Adv Exp Med Biol; 1999; 458():167-74. PubMed ID: 10549389
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Herpesvirus infections--indications for chemotherapy in dermato-venereology].
    Gross GE; Schumann J
    Hautarzt; 1990 Nov; 41(11):591-601. PubMed ID: 1703519
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acyclovir therapy of varicella-zoster virus infections in immunocompromised patients.
    Balfour HH; McMonigal KA; Bean B
    J Antimicrob Chemother; 1983 Sep; 12 Suppl B():169-79. PubMed ID: 6313596
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of acyclovir and vidarabine in immunocompromised children with varicella-zoster virus infection.
    Kunitomi T; Akazai A; Ikeda M; Oda M; Kodani N
    Acta Paediatr Jpn; 1989 Dec; 31(6):702-5. PubMed ID: 2516397
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Retrospective analysis of varicella zoster virus (VZV) copy DNA numbers in plasma of immunocompetent patients with herpes zoster, of immunocompromised patients with disseminated VZV disease, and of asymptomatic solid organ transplant recipients.
    Kronenberg A; Bossart W; Wuthrich RP; Cao C; Lautenschlager S; Wiegand ND; Mullhaupt B; Noll G; Mueller NJ; Speck RF
    Transpl Infect Dis; 2005; 7(3-4):116-21. PubMed ID: 16390399
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The future of varicella vaccine.
    Plotkin SA; Arbetter AA; Starr SE
    Postgrad Med J; 1985; 61 Suppl 4():155-62. PubMed ID: 3014474
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular and therapeutic aspects of varicella-zoster virus infection.
    Quinlivan M; Breuer J
    Expert Rev Mol Med; 2005 Aug; 7(15):1-24. PubMed ID: 16098235
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Reactivation of herpes zoster infection by varicella-zoster virus].
    Cvjetković D; Jovanović J; Hrnjaković-Cvjetković I; Brkić S; Bogdanović M
    Med Pregl; 1999; 52(3-5):125-8. PubMed ID: 10518396
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Acyclovir and infections caused by varicella-zoster viruses].
    Vildé JL; Longuet P
    Rev Prat; 1994 Oct; 44(16):2133-6. PubMed ID: 7984909
    [No Abstract]   [Full Text] [Related]  

  • 33. Varicella-zoster virus.
    Arvin AM
    Clin Microbiol Rev; 1996 Jul; 9(3):361-81. PubMed ID: 8809466
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of varicella-zoster virus infections.
    Bean B; Englund JA
    Clin Lab Med; 1987 Dec; 7(4):853-68. PubMed ID: 3319369
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiviral treatment in chickenpox and herpes zoster.
    Huff JC
    J Am Acad Dermatol; 1988 Jan; 18(1 Pt 2):204-6. PubMed ID: 3339143
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Varicella zoster virus infections in immunocompromised hosts. A review of the natural history and management.
    Balfour HH
    Am J Med; 1988 Aug; 85(2A):68-73. PubMed ID: 3044096
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Herpes zoster-associated morbidity in children undergoing chemotherapy for acute lymphoblastic leukaemia].
    Sørensen GV; Helgestad J; Rosthøj S
    Ugeskr Laeger; 2009 Nov; 171(46):3350-4. PubMed ID: 19925740
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early relapses of varicella-zoster virus infection in immunocompromised children treated with acyclovir.
    Mészner Z; Gyarmati E; Nyerges G; Simon M; Koller M
    Acta Paediatr Hung; 1990; 30(2):263-70. PubMed ID: 2248805
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Primary varicella-zoster virus infection--current knowledge, diagnostic and therapeutic approaches].
    Cvjetković D; Jovanović J; Hrnjaković-Cvjetković I
    Med Pregl; 2000; 53(5-6):272-6. PubMed ID: 11089369
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of varicella zoster infections in immunocompetent hosts.
    Peterslund NA
    Am J Med; 1988 Aug; 85(2A):74-8. PubMed ID: 3044097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 53.